>peptide 1 (44 aa)
MTDSWVVFVNAGTSSAVRLSPSASSLPLDHMRGYAPLLLCTPRDP
>peptide 2 (46 aa)
HGHPLLRLRRRRRRLLLLLIRLLRIRTVGGLHLRRSPNPLSLSFSL*
>peptide 3 (40 aa)
MGRFCKRWYLLGRTIKPLSFITTVGSHEGICTATVVHSSRS
>peptide 4 (54 aa)
WPSTAAAAEEAAAAVAAADSPVADQNRWWIASSPLSEPSLTLLLSLKLQNRIEE*
>CNT0006570
CATGGCCATCCACTGCTGCGGCTGCGGAGGAGGCGGCGGCGGCTGTTGCTGCTGCTGATTCGCCTGTTGCGGATCAGAACCGTTGGTGGATTGCATCTTC
GCCGCTCTCCGAACCCTCTCTCACTCTCCTTCTCTCTCTAAAATTACAGAACCGGATTGAAGAATAAGGAGTGAAGAGGATAAGAAGACAAAGAAGAAGA
GCCTAGTGAATCTCGAAGTCTATAGAGAGAGAGAGAGAGAGAGAGAGAGAAGGAGGCGTGAGGAGGACGGAGGCAGGGTTTGGGGGGTTGAGGGGTGGTG
GAGTCTGCGGTTACGGCTATAGAGAGGATTTGTTTTGGGGAGGATGACGGATTCATGGGTCGTTTTTGTAAACGCTGGTACCTCCTCGGCCGTACGATTA
AGCCCCTCAGCTTCATCACTACCGTTGGATCACATGAGGGGATATGCACCGCTACTGTTGTGCACTCCTCGCGATCCG
| Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
|---|---|---|---|---|---|---|---|---|
| VIT_19s0085g00840.t01 | Putative uncharacterized protein | protein coding | CNT0006570 | 90 | 81 | CDS | Trans |